Skip to content
Strength & muscleCohort study3 min read

Depressive symptoms linked to sarcopenia in Chinese adults, partly via disability

MoveVitals Editorial Collective · Study published · Reading updated

Original paper:Association between depressive symptoms and sarcopenia among middle-aged and elderly individuals in China: the mediation effect of activities of daily living (ADL) disability. · BMC psychiatry · 2024 · Original paper ↗

Key takeaway

Among 8,238 Chinese adults aged 45 and older, depressive symptoms were associated with higher odds of sarcopenia (OR 1.30, 95% CI 1.03-1.63), and disability in activities of daily living (ADL) accounted for 20.00% of that link. The data come from a survey analysed as an association, so they cannot show that depression leads to muscle loss.

Study design

Cohort study

Reading basis

Published abstract

Reading focus

Association & confounding

The research question

Depression and sarcopenia (loss of muscle mass and function) are both common in older Chinese adults, but how they connect is poorly understood. The authors tested whether difficulty with daily activities sits on the path between depressive symptoms and sarcopenia.

Who and how

Analysis of data from the China Health and Retirement Longitudinal Study (CHARLS) in 8,238 participants aged 45 years and older (3,358 men and 4,880 women). Depressive symptoms were measured with the Centre for Epidemiological Studies Depression scale. Logistic regression tested links between depressive symptoms, ADL disability and sarcopenia, adjusting for social activity, chronic diseases, demographic factors and lifestyle habits. A mediation analysis estimated how much of the depression-sarcopenia link ran through ADL disability. The abstract does not say how sarcopenia was defined.

What it found

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    Depressive symptoms were associated with higher odds of sarcopenia (OR 1.30, 95% CI 1.03-1.63, P = 0.0269).
  2. 2
    ADL disability was associated with sarcopenia even more strongly (OR 1.94, 95% CI 1.37-2.75, P < 0.001).
  3. 3
    ADL disability partly mediated the depression-sarcopenia association: estimated indirect effect 0.006 (95% CI 0.003, 0.008), a proportion mediated of 20.00%.

Limits & uncertainty

  1. 1
    The depression and sarcopenia measures appear to come from the same time point, so the direction of the link and the mediation order cannot be established; depression could also follow muscle loss.
  2. 2
    The mediation proportion of 20.00% means most of the association is not explained by ADL disability, and the odds ratio for depression has a wide interval (1.03-1.63).
  3. 3
    The abstract's recommendations about psychological support plus muscle-strengthening exercise go beyond what this analysis tested; the authors themselves call for longitudinal follow-up.
  4. 4
    This reading is based on the abstract only.

What to take from it

Low mood, trouble with daily tasks and low muscle mass tend to occur together in middle-aged and older Chinese adults, so any one of them is a reasonable prompt to look at the others. This does not show that treating depression prevents sarcopenia; concerns about mood or strength should be raised with a clinician.

Reading your own data

Grip strength tests are not typical wearable data, but daily steps, walking pace and activity levels from a watch can show whether everyday movement is declining. Track them with the same device over weeks and notice sustained drops, not a single low day.

How to read this evidence

Exposure precedes follow-up outcomes, but confounding and reverse causation can remain. A hazard ratio is not an individual absolute risk or a demonstrated intervention effect.

Authors’ structured abstract English

The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.

Background

Depressive symptoms and sarcopenia, often observed among middle-aged and elderly individuals, are significant health concerns in China, particularly given the country's rapidly aging population. Depressive symptoms, characterized by persistent feelings of sadness and loss of interest, can significantly impact quality of life. Little is known about the underlying pathway connecting these two conditions.

Methods

The data for this study were derived from the China Health and Retirement Longitudinal Study (CHARLS). Depressive symptoms were evaluated using the Centre for Epidemiological Studies Depression (CSED) scale. Logistic regression analyses were employed to investigate the association between depressive symptoms, activities of daily living (ADL) disability, and sarcopenia, while adjusting for potential confounding factors. The selection of predictor variables, including social activity, chronic diseases, demographic factors, and lifestyle habits, was based on their known associations with mental health, physical functioning and sarcopenia. These variables were included to ensure a comprehensive adjustment for potential confounding factors and to provide a more accurate estimation of the relationship between depressive symptoms and sarcopenia. Additionally, mediation analysis was conducted to assess the mediating role of ADL disability in the relationship between depressive symptoms and sarcopenia.

Results

A comprehensive study was conducted on a total of 8,238 participants aged 45 years and older, comprising 3,358 men and 4,880 women. Logistic regression analyses were conducted to identify significant associations between depressive symptoms (OR = 1.30, P = 0.0269,95%CI = 1.03-1.63), ADL disability (OR = 1.94, P < 0.001,95%CI = 1.37-2.75) and sarcopenia. The results revealed significant relationships among these variables. Furthermore, mediation effect analyses demonstrated that ADL disability partially mediated the association between depressive symptoms and sarcopenia (estimated indirect effect: 0.006, 95% CI: 0.003, 0.008, proportion of mediation effect: 20.00%).

Conclusions

The study underscores a significant association between depressive symptoms and sarcopenia among middle-aged and elderly individuals in China, with ADL disability acting as a mediator. These findings offer novel insights for targeted health interventions. Future interventions should effectively combat sarcopenia by integrating psychological support with muscle-strengthening exercise programs. By addressing both depressive symptoms and ADL disability, clinicians and public health professionals can enhance outcomes for this demographic. Collaborative efforts across disciplines are essential for providing comprehensive health management tailored to the needs of middle-aged and elderly individuals. Future research should longitudinally assess the impact of such integrated interventions on sarcopenia prevention and depressive symptom alleviation. Additionally, investigating the role of social and environmental factors in mediating this relationship is crucial for developing more effective health strategies for this vulnerable population.

Sources & attribution

Association between depressive symptoms and sarcopenia among middle-aged and elderly individuals in China: the mediation effect of activities of daily living (ADL) disability.

Li Q, Cen W, Yang T, Tao S.

BMC psychiatry · 2024-06-10

DOI: 10.1186/s12888-024-05885-y ↗PubMed · 38858698 ↗Europe PMC · Recorded licence: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

MoveVitals editorial interpretation · educational content · no individual clinical review recorded

Sources checked 2026-11-01

Practical guides

Read in context

·Overview of reviews

ACSM review of 137 reviews: resistance training works, and few programme details matter

The American College of Sports Medicine pooled 137 systematic reviews (over 30,000 healthy adults) and concluded that resistance training beats no exercise for strength, muscle size, power, endurance and several function tests. Few programme details changed results consistently: heavier loads (80% or more of one-repetition maximum) and 2 to 3 sets favoured strength, and at least 10 sets a week favoured muscle size, while training to failure, exercise type and periodization did not. It summarises reviews rather than new trials, gives no pooled effect sizes, and drew mostly on untrained adults and overlapping source trials.

Medicine & Science in Sports & Exercise

In-depth explainersRead study →
·Trial meta-analysis

Nearly every resistance training plan beat no exercise; heavy loads led for strength

In a network meta-analysis of randomised trials in healthy adults (178 studies and 5097 people for strength, 119 studies and 3364 people for muscle size), nearly all resistance training prescriptions beat no exercise. Higher-load, multiset, thrice-weekly training ranked best for strength (standardised mean difference 1.60, 95% credible interval 1.38 to 1.82) and higher-load, multiset, twice-weekly training for muscle size (0.66, 0.47 to 0.85). Most prescriptions could not be statistically separated from each other (the 95% interval contained zero in 91% of the comparisons between them) and risk of bias was moderate to high, so the rankings are tentative.

British Journal of Sports Medicine

In-depth explainersRead study →
·Observational meta-analysis

Muscle-strengthening linked to lower risk of death, heart disease, cancer and diabetes

Pooling 16 prospective cohort studies of adults, people who did muscle-strengthening activity had a 15% lower risk of all-cause mortality (RR 0.85, 95% CI 0.79 to 0.93) and a 17% lower risk of both cardiovascular disease and diabetes (RR 0.83 for each) than people who did none. The pooled mortality curve was lowest at about 40 min/week (RR 0.83), but whether larger amounts help or hurt is unclear. All of this is observational, from mostly US self-reported data, and the authors rated the certainty of evidence as very low for most outcomes.

British Journal of Sports Medicine

In-depth explainersRead study →
·Trial meta-analysis

Protein supplements and weight training: small extra gains, smaller in older adults

Pooling 49 randomised trials with 1,863 healthy adults who did resistance training for at least 6 weeks, protein supplements added 0.30 kg of fat-free mass (95% CI 0.09 to 0.52) and 2.49 kg of one-repetition-maximum strength (0.64 to 4.33) on top of training alone. These gains were small next to the effect of training itself, were weaker with older age, and the suggested plateau near 1.6 g/kg/day was not statistically significant (p=0.079). One author has received funding from the US National Dairy Council, which supported trials in the analysis.

British Journal of Sports Medicine

In-depth explainersRead study →
Strength & muscle →